文献速递医学教育与科研方法流行病学与生物统计

研究者失败感阻碍了因招募不佳而终止的临床试验的透明度

Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment.
PubMed 文献 · J Clin Epidemiol · 2022-02-04

该研究通过对来自瑞士、德国和加拿大的49名临床试验利益相关者进行半结构化定性访谈,探讨因参与者招募不佳而终止临床试验后的实践做法及其影响。研究发现,尽管利益相关者意识到提前终止试验会浪费资源、影响科学证据并带来负面个人与职业影响,但实践中透明度仍受阻碍,多数终止试验的研究者未通知利益相关者或发表结果。研究者的失败感及相关的负面情绪被确定为不够透明的关键原因。

要点

  • 多数因招募不佳而终止的试验的研究者未通知利益相关者或发表结果。
  • 研究者的失败感及负面情绪是透明度不足的关键原因。
  • 通知利益相关者和发表结果应依靠系统性方法而非仅个体研究者。

核心结论

  • 通知利益相关者和发表终止试验的结果不应仅依靠个体研究者,而应采取系统性方法。
  • 在卫生研究主动要求传播所有临床试验结果之前,很大程度上取决于个体研究者被激励去做正确的事。
  • 支持项目可能有助于参与终止试验的研究者,并促进透明度和经验教训的吸取。

研究设计与样本

  • 采用个体半结构化定性访谈,于2015年8月至2016年11月间对来自瑞士(n=39)、德国(n=9)和加拿大(n=1)的49名临床试验利益相关者进行访谈。

主要发现

  • 利益相关者意识到提前终止试验会浪费有限资源、对科学证据产生不利影响,并带来负面个人和职业影响。
  • 实践中障碍继续削弱试验终止的透明度,据报告多数终止试验的研究者未通知利益相关者或发表结果。
  • 研究者的失败感及相关的负面情绪被确定为研究者终止后不够透明的关键原因。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: When a randomized clinical trial (RCT) prematurely discontinues, it is essential that stakeholders do the right thing to ensure that lessons can be learnt and trust in clinical research is maintained. There is, however, a lack of evidence exploring this issue. This study aimed to examine clinical trial stakeholders' practices following trial discontinuation due to poor participant recruitment and their views on implications of such discontinuation. METHODS: Individual semi-structured qualitative interviews were conducted with 49 clinical trial stakeholders from Switzerland (n = 39), Germany (n = 9) and Canada (n = 1) between August 2015 and November 2016. RESULTS: After interviews with 49 clinical trial stakeholders (75% male presenting), it was found that stakeholders were aware of the risks of premature trial discontinuation wasting limited resources, adversely impacting scientific evidence, and having negative personal and professional implications. However, barriers continue to undermine transparency regarding trial discontinuation in practice, with it being reported that most investigators of discontinued trials are failing to notify stakeholders or publishing their results. Investigators sense of failure and associated negative emotions were identified as a key reason why investigators are not more transparent following discontinuation. CONCLUSION: The decision to notify stakeholders and publish results of a discontinued clinical trial should not rest solely on individual investigators but come from a systemic approach. However, until health research proactively requires the dissemination of results of all clinical trials, much will rest on individual investigators being motivated to do the right thing. Support programs might be helpful for investigators involved in discontinued trials and promote transparency and learning lessons.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Satalkar P, McLennan S, Elger BS, et al. Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment. J Clin Epidemiol. 2022. PMID: 35124187. doi:10.1016/j.jclinepi.2022.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。